Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation.
Lu W, Lyu H, Xiao X, Bai X, Zhang M, Wang J, Pu Y, Meng J, Zhang X, Zhu H, Yuan T, Wang B, Jin X, Cao X, Wang Z, Xie T, Meng H, Stepanov AV, Gabibov AG, An Y, Sun R, Zhang Y, Maschan MA, Zhu Z, Zhang H, Zhao M.
Lu W, et al. Among authors: maschan ma.
Leukemia. 2024 Jun;38(6):1419-1422. doi: 10.1038/s41375-024-02251-5. Epub 2024 Apr 17.
Leukemia. 2024.
PMID: 38632315
Free PMC article.
No abstract available.